Fast-track your progress with our leading-edge technology and deep expertise in viral vector and
nucleic acid services

Exothera SA is a Univercells company
WHO WE ARE

Full-service Contract Development and Manufacturing Organization

Exothera is a specialized CDMO delivering pre-clinical to commercial GMP manufacturing services for viral vector and RNA therapeutics and vaccines.

As a Univercells company, Exothera capitalizes on novel manufacturing technologies invented in-house and unparalleled bioprocessing expertise to help you impact patient lives. 

Viral Vector-based therapeutics development and manufacturing process GMP Platform
WHO WE ARE

Full-service Contract Development and Manufacturing Organization 

Exothera is a specialized CDMO delivering pre-clinical to commercial GMP manufacturing services for viral vector and RNA therapeutics and vaccines.

As a Univercells company, Exothera capitalizes on novel manufacturing technologies invented in-house and unparalleled bioprocessing expertise to help you impact patient lives. 

Viral Vector-based therapeutics development and manufacturing process GMP Platform
WHAT WE DO

Our Services

Viral vectors

Experience industry leading titers for AAV and AV while leveraging deep expertise in fixed bed and stirred tank processes from the inventors of the iCellis and Scale-X bioreactors.

Learn more about our experience with AAV, AV, VLP, MVA, LVV, baculovirus
and other viral vectors.

Nucleic acids

Achieve higher yields at consistently higher quality by harnessing NtensifyTM technology by Quantoom Biosciences.

By integrating our solutions into your evolution, we help you sidestep common process development and scale up hurdles to smooth the journey from concept to market.

WHAT WE DO

Our Services

Viral vectors

Experience industry leading titers for AAV and AV while leveraging deep expertise in fixed bed and stirred tank processes from the inventors of the iCellis and Scale-X bioreactors.

Learn more about our experience with AAV, AV, VLP, MVA, LVV, baculovirus and other viral vectors.

Nucleic acids

Achieve higher yields at consistently higher quality by harnessing NtensifyTM technology by Quantoom Biosciences.

By integrating our solutions into your evolution, we help you sidestep common process development and scale up hurdles to smooth the journey from concept to market.

TESTIMONIALS

What our customers think about our services

We are extremely satisfied with Exothera’s manufacturing capabilities, the full-service model, and the outstanding commitment to rapid manufacturing of our vaccine for the Phase I/II trials. This is everything we need from a CDMO.
Erkko Ylösmäki

Director Research and Development, Rokote Laboratories

We chose Exothera because we recognise the benefits of having a partner with extensive process design experience to rapidly scale the production of our novel COVID-19 vaccine candidate, CVXGA1. Exothera will enable us to produce millions of doses of our intranasal vaccine for Phase III trials.
Biao He

CEO & Founder, Cyanvac

These are impressive data.  I am very happy.  I would say that with Exothera I had one of the best CDMO experiences ever.
Steffen Mueller

President & CSO, Codagenix

92,548
(8,600)

square feet (square meters)
of facility space

+170

employees

up to 3,229
(600)

square feet (square meters) fixed bed

up to 2,000

liters scale stirred tanks

WHERE WE WORK

Our Facilities

Exothera is located in Belgium, south of Brussels in Charleroi as well as Andover, Massachusetts in the US.

WHERE WE WORK

Our Facilities

Exothera is located in Belgium, south of Brussels in Charleroi as well as
Andover, Massachusetts in the US.

State-of-the-art Facility and the Best Customer Experience to serve you and your patients

From discovery to GMP, our ecosystem of solutions is designed to
support you at every stage.

OUR APPROACH

Our Differentiators

Game-changing technologies

Developed in-house, our innovative viral vector and nucleic acid technologies offer world-first capabilities that can dramatically cut costs and timelines, without compromising quality.

Exceptional customer experience — 100% customer satisfaction

Our unwavering commitment to customer satisfaction is reflected in our outstanding customer survey scores. Our experienced team and attentive service mean you’re in safe hands.

Unrivaled capabilities from clinical to commercial

From discovery to GMP, our ecosystem of solutions is designed to support you at every stage. Our expertise in process development and scale-up ensures that you achieve the highest titers and the highest quality product on your journey to successful drug development and commercialization.

OUR APPROACH

Our Differentiators

Game-changing technologies

Developed in-house, our innovative viral vector and nucleic acid technologies offer world-first capabilities that can dramatically cut costs and timelines, without compromising quality.

Exceptional customer experience — 100% customer satisfaction

Our unwavering commitment to customer satisfaction is reflected in our outstanding customer survey scores. Our experienced team and attentive service mean you’re in safe hands.

Unrivaled capabilities from clinical to commercial

From discovery to GMP, our ecosystem of solutions is designed to support you at every stage. Our expertise in process development and scale-up ensures that you achieve the highest titers and the highest quality product on your journey to successful drug development and commercialization.

Trusted by

Exothera is unique in the CDMO industry with a 100% customer satisfaction for 3 years in a row

For any questions or requests

Please contact us and we will respond quickly!  

For any questions or requests

Please contact us and we will respond quickly!